KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers

KRAS encodes K-Ras proteins, which take part in the MAPK pathway. The expression level of KRAS is high in tumor patients. Our study compared KRAS expression levels between 33 kinds of tumor tissues. Additionally, we studied the association of KRAS expression levels with diagnostic and prognostic val...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Da, Wang, Lizhuang, Chen, Zheng, Zhang, Lijun, Xu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624065/
https://www.ncbi.nlm.nih.gov/pubmed/36330448
http://dx.doi.org/10.3389/fgene.2022.1024920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624065/
https://www.ncbi.nlm.nih.gov/pubmed/36330448
http://dx.doi.org/10.3389/fgene.2022.1024920

Ejemplares similares